Table 2 Characterization of patients with IST.
From: Inappropriate sinus tachycardia in post-COVID-19 syndrome
Reference values | Mean values | |
|---|---|---|
Laboratory tests | ||
NT-proBNP (pg/mL) | < 125 | 67.6 ± 59.6 |
Hs-Troponin I (pg/mL) | < 14 | 3.09 ± 4.2 |
Leucocytes (× 109/L) | 4.00–11.00 | 6.83 ± 1.7 |
Hemoglobin (g/dL) | 12.0–16.0 | 13.4 ± 0.7 |
TSH (µm/U) | 0.350–4.940 | 1.4 ± 0.5 |
IL-6 (pg/mL) | 0–6.40 | 2.2 ± 1.1 |
Ferritin (ng/mL) | 15–160 | 50.4 ± 37.4 |
C-reactive protein (mg/L) | 0.00–5.00 | 1.1 ± 1.3 |
D-Dimer (ng/mL) | 0–500 | 247.7 ± 133.2 |
Fibrinogen | 150–450 | 374.9 ± 54.1 |
24-h urine 3-Metoxiadrenaline (mg/L) | 0.02–0.350 | 0.123 ± 0.120 |
24-h urine 3-Metoxinoradrenaline (mg/L) | 0.03–0.440 | 0.178 ± 0.189 |
Exercise capacity test | ||
6MWT (m) | 392.7 ± 83.2 | |
6MWT theoretical (%) | 60.1 ± 12.1 | |
Quality of life test (EQ-5D-5L) | Score reference valuesa | Mean values |
|---|---|---|
Mobility | 1–5 | 3.6 ± 1.1 |
Self-care | 1–5 | 2.4 ± 1.2 |
Usual activities | 1–5 | 3.5 ± 0.9 |
Pain/discomfort | 1–5 | 3.0 ± 1.0 |
Anxiety/depression | 1–5 | 2.9 ± 1.2 |
Health state scale (Visual Analogue Scale) | 0–100 | 39.6 ± 20.7 |